You are here

SIRT Aids Colorectal Cancer Patients With Metastases Confined to the Liver

Dr. Guy van Hazel, Professor of Medicine at the University of Western Australia, discusses updated findings from the SIRFLOX study. Selective internal radiation therapy extended progression-free survival by 8.7 months among metastatic colorectal cancer patients with no extrahepatic metastases; adding bevacizumab had little effect.

ESMO World Congress on Gastrointestinal Cancer, July 2015